• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/60 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol

Patent holdings for IPC class A61K 47/60

Total number of patents in this class: 3721

10-year publication summary

142
249
391
472
459
490
471
446
392
166
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Nektar Therapeutics
438
87
Hanmi Pharm. Co., Ltd.
569
72
The Regents of the University of California
19812
58
Bristol-myers Squibb Company
4892
47
Ascendis Pharma A/S
178
44
The Johns Hopkins University
5642
41
Massachusetts Institute of Technology
10013
37
Ascendis Pharma Growth Disorders A/S
54
36
Board of Regents, The University of Texas System
5751
34
Synthorx, Inc.
77
33
Quiapeg Pharmaceuticals AB
45
26
Amgen Inc.
4047
25
Janssen Pharmaceutica N.V.
3423
24
Northwestern University
3364
23
Ascendis Pharma Bone Diseases A/S
45
23
The Board of Trustees of the Leland Stanford Junior University
6365
22
NOK Corporation
2210
22
Ambrx, Inc.
181
20
SeaGen Inc
580
20
Yale University
2358
19
Other owners 3008